Mesothelioma, a rare and aggressive cancer primarily caused by asbestos exposure, poses significant challenges not only treatment but also in the...

In a new study led by Johns Hopkins Medicine, the drug RK-33 has demonstrated promise in treating breast cancer that has spread to the bone (breast...

A study published in Clinical Cancer Research confirmed that tissue stiffening in the most common types of breast cancer, HER2-negative, can...

 Adron Homes and Properties, a leading real estate company, reaffirms its dedication to corporate social responsibility (CSR) through its fourth...

In a breakthrough study published in Cell Reports, researchers from Professor Idit Shachar’s laboratory at the Weizmann Institute of Science have...

University of Oregon biologists have uncovered a mechanism by which a well-known breast cancer gene also influences fertility. Mutations in the BRCA1...

Medicaid expansion under the Affordable Care Act (ACA) is associated with better outcomes for patients with hormone receptor (HR)-negative, human...

Using a gene signature technique to tailor chemotherapy for patients with early triple-negative breast cancer shows promise as a way to improve...

Medicaid expansion linked to better cancer care and survival rates for patients with aggressive breast cancer.

HER2-targeted therapies, originally developed for breast cancer, may also benefit patients with rare bile duct cancer and HER2-mutated breast...